Interindividual Variation in Excretion of Curcumin
University of Massachusetts Amherst
1 other identifier
interventional
8
1 country
1
Brief Summary
The objective of this project is to elucidate the interindividual variations in excretion of curcumin and its metabolites.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2018
CompletedFirst Submitted
Initial submission to the registry
November 15, 2018
CompletedFirst Posted
Study publicly available on registry
November 19, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2019
CompletedDecember 17, 2020
March 1, 2020
6 months
November 15, 2018
December 14, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Determine the concentration of curcumin and its metabolites in the human fecal samples.
Utilize LC-MSMS to identify and quantify the curcumin and its metabolites in the subjects fecal samples.
3-4 weeks
Study Arms (1)
Curcumin
EXPERIMENTALsubjects will be assigned to consume one capsule of curcumin (330 mg of curcumin per capsule) three times a day (one capsule with each meal).
Interventions
subjects will be assigned to consume one capsule of curcumin (330 mg of curcumin per capsule) three times a day (one capsule with each meal).
Eligibility Criteria
You may qualify if:
- year old healthy adults
You may not qualify if:
- Additionally, this study excludes menopausal women, those using hormone-based contraceptives, those with abnormal menstrual cycles, and those who are pregnant, lactating or planning to become pregnant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute for Applied Life Sciences
Amherst, Massachusetts, 01003, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 15, 2018
First Posted
November 19, 2018
Study Start
September 1, 2018
Primary Completion
March 1, 2019
Study Completion
October 1, 2019
Last Updated
December 17, 2020
Record last verified: 2020-03